期刊文献+

基于临床和Gd-EOB-DTPA增强磁共振特征构建中国肝癌临床分期Ⅰa期肝细胞癌微血管侵犯的列线图预测模型 被引量:2

The value of nomogram for predicting microvascular invasion based on clinical and Gd-EOB-DTPA-enhanced magnetic resonance imaging features
原文传递
导出
摘要 目的探讨中国肝癌临床分期(CNLC)为Ⅰa期的肝细胞癌(HCC)微血管侵犯的危险因素,构建预测微血管侵犯的列线图模型。方法选取2016—2020年在中国医学科学院肿瘤医院行根治性手术切除的Ⅰa期HCC患者104例,收集患者的临床特征、实验室检查指标和术前肝胆特异性对比剂增强磁共振影像学特征。采用单因素和多因素logistic回归分析确定微血管侵犯的危险因素,构建列线图预测模型,并对列线图预测模型进行内部验证。结果根据组织病理学诊断结果将患者分为微血管侵犯阳性组(28例)和微血管侵犯阴性组(76例)。单因素和多因素logistic回归分析显示,甲胎蛋白(OR=3.3,95%CI:0.9~12.6)、总胆红素(OR=6.8,95%CI:1.3~36.8)、凝血酶原时间(OR=0.2,95%CI:0.0~0.7)、肝胆期肿瘤边缘(OR=4.6,95%CI:1.1~18.8)、肿瘤包膜(OR=0.3,95%CI:0.1~1.1)是微血管侵犯的影响因素(均P<0.1),在此基础上构建HCC微血管侵犯列线图预测模型。内部验证结果显示,该模型受试者工作特性曲线的曲线下面积为0.867(95%CI:0.791~0.944),灵敏度为0.786,特异度为0.829。校准曲线显示,列线图模型的预测曲线接近理想曲线,一致性较好。Hosmer-Lemeshow检验显示,列线图模型的预测结果与实际发生情况差异无统计学意义(P=0.956)。结论结合临床和影像学特征的列线图预测模型可用于预测CNLCⅠa期HCC微血管侵犯状态,为患者的个体化治疗策略提供指导。 Objective To investigate the risk factors of microvascular invasion(MVI)in China liver cancer staging system stageⅠa(CNLCⅠa)hepatocellular carcinoma(HCC),and develop a nomogram for predicting MVI based on clinical and radiographic data.Methods This retrospective study focused on CNLCⅠa HCC patients who underwent radical resection at the Cancer Hospital,Chinese Academy of Medical Sciences from January 2016 to December 2020.Patients′clinical characteristics and laboratory test results and pre-surgery gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid(Gd-EOB-DTPA)-enhanced magnetic resonance imaging results were collected.The clinical and radiographic risk factors for MVI were identified by univariate and multivariate logistic regression analyses and used for the construction of the predictive nomogram.The nomogram model was then internally validated,and its performance was assessed.Results A total of 104 patients were divided into the MVI-positive group(n=28)and the MVI-negative group(n=76).Multivariate logistic regression analysis at the P<0.1 level identified serum alpha-ferroprotein>7 ng/ml,total bilirubin>21μmol/L,prothrombin time>12.5 s,non-smooth margin,and incomplete or absent capsule as risk factors of MVI,based on which a nomogram model was built.The model achieved an area under the curve(AUC)value of 0.867(95%confidence interval,0.791-0.944)in the internal validation.The sensitivity and specificity of the nomogram model were 0.786 and 0.829,respectively,with the prediction curve nearly overlapping the ideal curve.Based on the Hosmer-Lemeshow test,the predicted and real results were not significantly different(P=0.956).Conclusions The probability of MVI of CNLCⅠa HCC can be objectively predicted by the monogram model that quantifies the clinical and radiographic risk factors.The model can also help clinicians select individualized surgical plans to improve the long-term prognosis of patients.
作者 郭倩倩 马霄虹 韩融诚 赵心明 Guo Qianqian;Ma Xiaohong;Han Rongcheng;Zhao Xinming(Department of Diagnostic Radiology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Diagnostic Radiology,Guizhou Provincial People's Hospital,Guiyang 550002,China)
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2023年第8期666-672,共7页 Chinese Journal of Oncology
关键词 肝细胞 微血管侵犯 磁共振成像 列线图 Carcinoma,Hepatocellular Microvascular invasion Magnetic resonance imaging Nomogram
  • 相关文献

参考文献3

二级参考文献30

  • 1Han Wang,Peng-Cheng Du,Meng-Chao Wu,Wen-Ming Cong.Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion[J].Hepatobiliary Surgery and Nutrition,2018,7(6):418-428. 被引量:29
  • 2Katsunori Imai,Hideo Baba.Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: is it time to reconsider the current treatment guidelines?[J].Hepatobiliary Surgery and Nutrition,2018,7(4):300-301. 被引量:1
  • 3Wei Wu, Deng-Fu Yao, Yong-Mei Yuan, Ji-Wei Fan, Xiu-Feng Lu, Xiao-Hua Li, Li-Wei Qiu, Lei Zong and Xin-Hua Wu Research Center of Clinical Molecular Biology, Affiliated Hospital of Nantong University, Nantong 226001, China.Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2006,5(4):538-544. 被引量:26
  • 4Kentaroh Yamamoto,Hiroshi Imamura,Yutaka Matsuyama,Yukio Kume,Hitoshi Ikeda,Gary L. Norman,Zakera Shums,Taku Aoki,Kiyoshi Hasegawa,Yoshifumi Beck,Yasuhiko Sugawara,Norihiro Kokudo.AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC[J].Journal of Gastroenterology.2010(12)
  • 5Stephen B. Edge MD,Carolyn C. Compton MD, PhD.The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM[J].Annals of Surgical Oncology.2010(6)
  • 6Kentaroh Yamamoto MD,Hiroshi Imamura MD,Yutaka Matsuyama PhD,Kiyoshi Hasegawa MD,Yoshifumi Beck MD,Yasuhiko Sugawara MD,Masatoshi Makuuchi MD,Norihiro Kokudo MD.Significance of Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy[J].Annals of Surgical Oncology.2009(10)
  • 7Brian I. Carr,Futoshi Kanke,Margaret Wise,Shinji Satomura.Clinical Evaluation of Lens Culinaris Agglutinin-Reactive α-Fetoprotein and Des-γ-Carboxy Prothrombin in Histologically Proven Hepatocellular Carcinoma in the United States[J].Digestive Diseases and Sciences.2007(3)
  • 8Dr. Akinori Kasahara MD,Norio Hayashi MD,Hideyuki Fusamoto MD,Yoshio Kawada MD,Yasukiyo Imai MD,Hideo Yamamoto MD,Eijiro Hayashi MD,Toshio Ogihara MD,Takenobu Kamada MD.Clinical evaluation of plasma des-γ-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes[J].Digestive Diseases and Sciences.1993(12)
  • 9J.M. Llovet,A. Borroughs,J. Bruix.Hepatocellular carcinoma[].The Lancet.2003
  • 10Collier J,Sherman M.Screening for hepatocellular carci- noma[].Hepatology.1998

共引文献38

同被引文献28

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部